Nephrogenic systemic fibrosis–a rapidly progressive disabling disease with limited therapeutic options

Gisela Schieren(Heinrich Heine University Düsseldorf), Nikolaus Wirtz(Krankenhaus der Barmherzigen Brüder Trier), Peter Altmeyer(Ruhr University Bochum), Lars Christian Rump(Heinrich Heine University Düsseldorf), Stefan M. Weiner(Krankenhaus der Barmherzigen Brüder Trier), Alexander Kreuter(Ruhr University Bochum)

Journal of the American Academy of Dermatology

October 16, 2009

10.1016/j.jaad.2009.03.040

Cited by 34

Abstract

Related Papers

Gadolinium – a specific trigger for the development of nephrogenic fibrosing dermopathy and nephrogenic systemic fibrosis?

Thomas Grobner|Nephrology Dialysis Transplantation|2006|1.8k

Scleromyxoedema-like cutaneous diseases in renal-dialysis patients

Shawn E. Cowper, H Robin, Steven M. Steinberg et al.|The Lancet|2000|878

What nephrologists need to know about gadolinium

Jeffrey G. Penfield, Robert F. Reilly|Nature Clinical Practice Nephrology|2007|333

Description of 12 Cases of Nephrogenic Fibrosing Dermopathy and Review of the Literature

Fabian A. Mendoza, Carol M. Artlett, Nora Sandorfi et al.|Seminars in Arthritis and Rheumatism|2006|262

Nephrogenic Systemic Fibrosis

Aneet Deo, Mitchell Fogel, Shawn E. Cowper|Clinical Journal of the American Society of Nephrology|2007|258